Clinical Trials Directory

Trials / Unknown

UnknownNCT00750217

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches

Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches: A Study on Practicability With Patients Maintained With Daily Dosages Between 60mg and 100mg Methadone.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Psychiatric University Hospital, Zurich · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Buprenorphine is an important alternative to methadone in the maintenance treatment of heroin addiction. Transfer from methadone to buprenorphine requires a reduction of daily methadone dosage below 30 mg to avoid withdrawal after the first buprenorphine intake. The study hypothesis states that the transfer from a daily methadone dosage between 60 mg and 100 mg to buprenorphine can be carried out without withdrawal using buprenorphine patches (35 micro grams per hour) within 12 to 48 hours after last methadone intake.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine patch and sublingual tabletsBuprenorphine patch: 35 micro grams per hour 12 to 48 hours after last methadone intake. Buprenorphine sublingual tablets: 2mg 48 and 60 hours after last methadone intake; 8mg 72 and 84 hours after last methadone intake; 8mg 96, 102 and 109 hours after last methadone intake.

Timeline

Start date
2008-08-01
Primary completion
2009-02-01
Completion
2009-05-01
First posted
2008-09-10
Last updated
2008-09-10

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00750217. Inclusion in this directory is not an endorsement.